Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 USD | -4.58% | +1.08% | -44.52% |
14/05 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
09/05 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.52% | 48Cr | |
+33.63% | 5.08TCr | |
-0.09% | 4.28TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.95TCr | |
+11.18% | 2.61TCr | |
-21.95% | 1.91TCr | |
+8.61% | 1.31TCr | |
+28.31% | 1.22TCr | |
+24.73% | 1.21TCr |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- SVB Securities Trims Price Target on Editas Medicine to $6 From $7, Maintains Market Perform Rating